SCHEMBL873565

SCHEMBL873565

O=C(O)C(=O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28040988 0.97
SCHEMBL28050407 0.97
SCHEMBL15910004 0.88 CES2 (0.39)
SCHEMBL873570 0.87 CES2 (0.67)
SCHEMBL873874 0.87
SCHEMBL18759144 0.86 ALDH1A1 (0.40)
SCHEMBL25248339 0.84 CES2 (0.63)
SCHEMBL2650157 0.84 CES2 (0.72)
SCHEMBL6159646 0.84 CES2 (0.72)
SCHEMBL18199938 0.84 CES2 (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120005847-A Alpha-hydroxy-beta-keto acid synthase for catalyzing alpha-keto acid coupling reaction 北京大学 2025-05-16 CN claimed
EP-2643000-A2 THERAPEUTIC PIPERAZINES Dart Neuroscience (Cayman) Ltd (KY) 2013-10-02 EP claimed
WO-2012040258-A2 THERAPEUTIC PIPERAZINES HELICON THERAPEUTICS, INC. (US) 2012-03-29 WO claimed
US-20110065691-A1 THERAPEUTIC PIPERAZINES DART NEUROSCIENCE (CAYMAN) LTD. (KY) 2011-03-17 US claimed
EP-4729513-A1 A-KETO ACID AMIDE OR SUBSTITUTED OXALIC ACID AMIDE ESTER COMPOUND AND COMPOSITION THEREOF Nanjing Chempion Biotechnology Co., Ltd. (CN) 2026-04-22 EP disclosed
US-20260055113-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER HOFFMANN-LA ROCHE INC. (US) 2026-02-26 US disclosed
US-12522584-B2 3,4-dihydroisoquinoline compound and use thereof CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD (CN) 2026-01-13 US disclosed
US-20250353817-A1 INTERLUKIN-17A INHIBITORS AND USES THEREOF GILEAD SCIENCES INC (US) 2025-11-20 US disclosed
EP-4568965-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2025-06-18 EP disclosed
US-20250188040-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS INC 2025-06-12 US disclosed
EP-4559912-A1 SULFUR-CONTAINING HETEROAROMATIC RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF Evopoint Biosciences Co., Ltd. (CN) 2025-05-28 EP disclosed
CN-120005847-A Alpha-hydroxy-beta-keto acid synthase for catalyzing alpha-keto acid coupling reaction 北京大学 2025-05-16 CN disclosed
EP-0108708-B1 N-(CYCLOPROPYL-TRIAZINYL- AND -PYRIMIDINYL)-N'-(ARYLSULFONYL) UREAS WITH HERBICIDAL ACTIVITY CIBA-GEIGY AG (CH) 1989-06-14 EP disclosed
US-4600428-A N-(cyclopropyl-pyrimidinyl-N'-(aryl-sulfonyl) ureas having herbicidal activity CIBA-GEIGY CORPORATION (US) 1986-07-15 US disclosed
EP-0148004-A2 Cephalosporin antibiotics GLAXO GROUP LIMITED (GB) 1985-07-10 EP disclosed
WO-1985002181-A1 PREPARATION OF CYCLIC-KETO-ACIDS ETHYL CORPORATION (US) 1985-05-23 WO disclosed
EP-0141876-A1 Preparation of cyclic-keto-acids ETHYL CORPORATION (US) 1985-05-22 EP disclosed
US-4515626-A PLANT GROWTH REGULATORS CIBA GEIGY CORPORATION (US) 1985-05-07 US disclosed
US-4473706-A Preparation of cyclic-keto-acids ETHYL CORPORATION (US) 1984-09-25 US disclosed
EP-0108708-A2 N-(cyclopropyl-triazinyl- and -pyrimidinyl)-N'-(arylsulfonyl) ureas with herbicidal activity CIBA-GEIGY AG (CH) 1984-05-16 EP disclosed